Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 63.53
+0.68 (1.08%)
At close: Dec 5, 2025
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Exact Sciences stock at 2.87%, Revolution Medicines at 2.63%, Avidity Biosciences at 2.39%, Insmed at 2.25%, and Natera at 2.14%.
Total Holdings
10
Top 10 Percentage
22.49%
Asset Class
Equity
ETF Category
Health Care
Assets
39.35M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | EXAS | Exact Sciences Corporation | 2.87% |
| 2 | RVMD | Revolution Medicines, Inc. | 2.63% |
| 3 | RNA | Avidity Biosciences, Inc. | 2.39% |
| 4 | INSM | Insmed Incorporated | 2.25% |
| 5 | NTRA | Natera, Inc. | 2.14% |
| 6 | BBIO | BridgeBio Pharma, Inc. | 2.10% |
| 7 | REGN | Regeneron Pharmaceuticals, Inc. | 2.10% |
| 8 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.09% |
| 9 | IONS | Ionis Pharmaceuticals, Inc. | 1.99% |
| 10 | BIIB | Biogen Inc. | 1.94% |
As of Dec 2, 2025